Fresenius Divests Brazilian Sites To EMS Amid Structural Streamlining
The Company Sold A Generic Injectable Manufacturing Plant For An Undisclosed Sum
The divestment marks a further step in Fresenius’ ongoing strategy towards a more optimized and simplified company structure while doubling down on new endeavors in the Biopharma space.
